Skip to main navigation Skip to search Skip to main content

A Phase 2, Open-Label, Basket Study of Atrasentan in Patients with Proteinuric Glomerular Diseases (The AFFINITY Study)

  • Ryan, Jessica (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date20/12/21 → 19/12/26

Keywords

  • phase 2 study
  • treatment effficacy
  • treatment safety
  • glomerular inflammation

Clinical Trial Phase

  • Phase II